DocWire News Editors

DocwireNews

<p>On Monday, the Food and Drug Administration (FDA) issued a warning against the use of several vaginal rejuvenation procedures. Utilizing laser and ultrasound treatment, these procedures are not approved by the FDA and have been reported to cause painful burns in patients.<p>Specifically, the FDA is warning against the use of energy-based devices, such as laser or radiofrequency, for these rejuvenation procedures. These devices are FDA approved for use in removing pre-cancerous or abnormal cervical and vaginal tissues, and genital warts, but is not approved for cosmetic use. In their statement, the FDA also claims that use of energy-based devices for &ldquo;non-surgical vaginal procedures to treat symptoms related to menopause, urinary incontinence, or sexual function may be associated with serious adverse events.&rdquo; Vaginal rejuvenation is a vague term that commonly refers to nonsurgical procedures intended to treat vaginal tightness, loss of muscle tone, various pains, and lack of sexual sensation.</p><p>The FDA stated that these procedures have not been cleared or approved to increase sexual pleasure, tighten muscles, or offer pain relief. In fact, the procedure has often been reported to cause the pain it is designed to relieve during sexual activity. Other adverse events that can result from these procedures include vaginal burns, chronic or recurring pain, and scarring.</p><p>However, if you&rsquo;re struggling with something like vaginal odor, then you can say goodbye to it with these <a href="https://getflowerpower.com">boric acid suppositories</a> that can help you have a balanced vagina!</p><div id="attachment_4790556" style="width: 454px" class="wp-caption aligncenter"><img aria-describedby="caption-attachment-4790556" loading="lazy" decoding="async" class="wp-image-4790556" src="https://mumcdnstorage.blob.core.windows.net/dwnews/2018/07/ultra-femme-ad.png" alt="vaginal rejuvenation" width="444" height="292">
<p id="caption-attachment-4790556" class="wp-caption-text">Advertisement for Ultra Femme 360, a vaginal rejuvenation product.</p>
</div><p>Companies who manufacture these devices have been heavily marketing these products, often making claims that lack credibility. One company, Alma Lasers, advertises their device as one that can provide &ldquo;a better feminine life.&rdquo; BTL markets their Femme 360 product as &ldquo;a noninvasive, no downtime procedure with minimal risk,&rdquo; using enticing claims to help women bring their &ldquo;sexy body back&rdquo;.</p><p>To combat inappropriate marketing of these devices, the FDA has contacted seven companies who are currently marketing their devices outside of their approved and intended uses.These companies include Alma Lasers, BTL Aesthetics, BTL Industries, Cynosure, InMode, Sciton and Thermigen. In their messages to these companies, the FDA voiced their concerns and claims they &ldquo;will be monitoring their claims about uses of their products&rdquo;.</p><p><iframe loading="lazy" src="https://www.youtube.com/embed/r9RwsGPsKv4" width="720" height="415" frameborder="0" allowfullscreen="allowfullscreen"></iframe></p><p>Sources: <a href="https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm615013.htm">FDA</a>, <a href="https://www.nbcnews.com/health/health-news/fda-warns-companies-about-deceptive-vaginal-rejuvenation-claims-n895811">NBC</a>, <a href="https://www.drswclinics.com/treatments/exclusive-to-dr-sw/ultra-femme-360/">Dr. SW Clinics</a></p></p>


Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

FDA Issues Warning Against Vaginal Rejuvenation Procedures

Health & Wellness

On Monday, the Food and Drug Administration (FDA) issued a warning against the use of several vaginal rejuvenation procedures. Utilizing laser and ultrasound treatment, these ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe